Immune-Onc Therapeutics Receives $7,000,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
    Immune-Onc Therapeutics
  • Mailing Address
    1059 East Meadow Cir. Palo Alto, CA 94303 USA
  • Company Description
    Immune-Onc Therapeutics, Inc. is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The financing will support discovery and development of novel antibodies with breakthrough potential in the area of cancer immunotherapy.
  • M&A Terms
  • Venture Investor
    CLI Ventures

Trending on Xconomy